You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 13, 2025
In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data
Published on: April 18, 2019
Kevin Pierre1, Vanessa Molina2, Shil Shukla2
1University of Florida Department of Radiology, Gainesville 32603, Florida, USA.
Chronic traumatic encephalopathy (CTE) is a brain disease caused by repeated head injuries. Diagnosing CTE is difficult because symptoms vary and current methods are not reliable. This review article looks at new ways to detect CTE using brain scans and fluid markers. Techniques like PET CT and DTI show promise in identifying brain changes linked to CTE. Fluid markers like p-tau and TREM2 may help detect the disease early. The authors suggest combining multiple diagnostic tools to improve accuracy. While these methods are promising, more research is needed to confirm their effectiveness.
Area of Science:
Background:
Chronic traumatic encephalopathy (CTE) is a neurodegenerative condition linked to repeated mild traumatic brain injuries. Prior research has shown that CTE is diagnosed primarily through clinical symptoms and imaging, though these methods lack consistency. No definitive pre-mortem diagnostic tool exists for CTE. Current approaches often fail to distinguish CTE from other neurodegenerative diseases. Post-mortem examination remains the only definitive diagnostic method. This uncertainty has driven recent efforts to develop more reliable diagnostic techniques. Researchers have explored both imaging and fluid biomarkers to improve detection. However, the field lacks standardized protocols for early diagnosis. These challenges highlight the need for more accurate and accessible diagnostic tools.
Purpose Of The Study:
This review article aims to summarize recent advances in CTE diagnosis, focusing on imaging and fluid biomarker approaches. The study addresses the gap in reliable pre-mortem diagnostic methods for CTE. It evaluates current diagnostic strategies and highlights promising research directions. The authors seek to clarify the limitations of existing techniques and identify potential solutions. By synthesizing recent findings, the study offers a comprehensive overview of CTE diagnostics. The goal is to inform future diagnostic development and clinical practice. The review emphasizes the importance of integrating multiple diagnostic modalities. It provides a foundation for understanding the evolving landscape of CTE detection.
Main Methods:
The authors conducted a review of recent literature on CTE diagnostics. They analyzed studies focusing on imaging and fluid biomarker techniques. Quantitative structural analyses, DTI, fMRI, MRS, SWI, and PET CT were evaluated for diagnostic potential. Fluid biomarkers such as p-tau, TREM2, CCL11, NfL, and GFAP were also examined. The review approach included assessing the strengths and limitations of each method. The authors synthesized findings to identify patterns and trends in the literature. They evaluated the consistency and reliability of each diagnostic approach. The synthesis provides a roadmap for future research and clinical application.
Main Results:
Quantitative structural analyses showed promise in detecting CTE-related brain changes. DTI revealed altered white matter integrity in CTE patients. fMRI indicated disrupted functional connectivity in affected regions. MRS detected metabolic changes consistent with neurodegeneration. SWI identified microhemorrhages linked to CTE pathology. PET CT demonstrated abnormal tau accumulation in specific brain areas. Fluid biomarkers like p-tau and TREM2 correlated with CTE severity. These findings suggest that multimodal approaches may enhance diagnostic accuracy.
Conclusions:
The authors propose that multimodal imaging and fluid biomarker approaches may improve CTE diagnosis. They suggest that quantitative structural analyses and DTI offer valuable diagnostic insights. The review highlights the potential of PET CT in detecting tau pathology. Fluid biomarkers like p-tau and TREM2 may serve as early diagnostic indicators. The authors emphasize the need for standardized protocols in CTE research. They propose that integrating multiple diagnostic techniques could enhance diagnostic reliability. The findings suggest that current methods remain insufficient for definitive pre-mortem diagnosis. The authors recommend further research to validate and refine these diagnostic approaches.
Recent research suggests that multimodal imaging and fluid biomarkers may improve CTE diagnosis.
PET CT has shown potential in detecting abnormal tau accumulation in CTE patients.
p-tau levels correlate with CTE severity and may indicate early disease progression.
DTI detects altered white matter integrity, a potential marker of CTE pathology.
MRS identifies metabolic changes in the brain consistent with neurodegeneration.
The authors propose that integrating multiple diagnostic techniques could enhance CTE detection.
